Cargando…
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis
Immune checkpoint inhibitors (ICIs) has revolutionized the treatment of different advanced solid tumors, but most patients develop severe immune-related adverse events (irAEs). Although a bi-directional crosstalk between bone and immune systems is widely described, the effect of ICIs on the skeleton...
Autores principales: | Pantano, Francesco, Tramontana, Flavia, Iuliani, Michele, Leanza, Giulia, Simonetti, Sonia, Piccoli, Alessandra, Paviglianiti, Annalisa, Cortellini, Alessio, Spinelli, Gian Paolo, Longo, Umile Giuseppe, Strollo, Rocky, Vincenzi, Bruno, Tonini, Giuseppe, Napoli, Nicola, Santini, Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633734/ https://www.ncbi.nlm.nih.gov/pubmed/36338920 http://dx.doi.org/10.1016/j.jbo.2022.100459 |
Ejemplares similares
-
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment
por: Iuliani, Michele, et al.
Publicado: (2022) -
Current and Emerging Biomarkers Predicting Bone Metastasis Development
por: Iuliani, Michele, et al.
Publicado: (2020) -
MicroRNAs and Bone Metastasis: A New Challenge
por: Croset, Martine, et al.
Publicado: (2014) -
Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
por: Iuliani, Michele, et al.
Publicado: (2021) -
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms
por: Ribelli, Giulia, et al.
Publicado: (2021)